Carrageenan is a potent inhibitor of papillomavirus infection - Wikidata - awgldk - TriplyDB

Carrageenan is a potent inhibitor of papillomavirus infection

Carrageenan is a potent inhibitor of papillomavirus infection

http://www.wikidata.org/entity/Q21089628

about

Cutaneous and mucosal human papillomaviruses differ in net surface charge, potential impact on tropism Iota-Carrageenan is a potent inhibitor of rhinovirus infection Efficacy of Carraguard-based microbicides in vivo despite variable in vitro activity Current understanding of the mechanism of HPV infection Efficacy and safety of an antiviral Iota-Carrageenan nasal spray: a randomized, double-blind, placebo-controlled exploratory study in volunteers with early symptoms of the common cold Biomedical Biopolymers, their Origin and Evolution in Biomedical Sciences: A Systematic Review Antiviral Potential of Algae Polysaccharides Isolated from Marine Sources: A Review Role of Marine Natural Products in the Genesis of Antiviral Agents Human Papillomavirus: Current and Future RNAi Therapeutic Strategies for Cervical Cancer Papillomavirus Infectious Pathways: A Comparison of Systems Multipurpose prevention technologies: the future of HIV and STI protection The cytoskeleton in papillomavirus infection Marine algae sulfated polysaccharides for tissue engineering and drug delivery approaches Concepts of papillomavirus entry into host cells A Novel Microbicide/Contraceptive Intravaginal Ring Protects Macaque Genital Mucosa against SHIV-RT Infection Ex Vivo Entry of human papillomavirus type 16 by actin-dependent, clathrin- and lipid raft-independent endocytosis Structural Basis of Oligosaccharide Receptor Recognition by Human Papillomavirus Target cell cyclophilins facilitate human papillomavirus type 16 infection Differential dependence on host cell glycosaminoglycans for infection of epithelial cells by high-risk HPV types Alginate hydrogel protects encapsulated hepatic HuH-7 cells against hepatitis C virus and other viral infections Non-clinical safety evaluation of intranasal iota-carrageenan Specific Inhibitory Effect of κ-Carrageenan Polysaccharide on Swine Pandemic 2009 H1N1 Influenza Virus The Intranasal Application of Zanamivir and Carrageenan Is Synergistically Active against Influenza A Virus in the Murine Model Iota-carrageenan is a potent inhibitor of influenza A virus infection Inhibition of Influenza A Virus Infection by Fucoidan Targeting Viral Neuraminidase and Cellular EGFR Pathway Efficacy and safety of iota-carrageenan nasal spray versus placebo in early treatment of the common cold in adults: the ICICC trial A review of current intravaginal drug delivery approaches employed for the prophylaxis of HIV/AIDS and prevention of sexually transmitted infections Carrageenan nasal spray in virus confirmed common cold: individual patient data analysis of two randomized controlled trials.Adsorption of human papillomavirus 16 to live human sperm.Potential anti-HPV and related cancer agents from marine resources: an overview.Impact of inhibitors and L2 antibodies upon the infectivity of diverse alpha and beta human papillomavirus types.Evaluation of WLBU2 peptide and 3-O-octyl-sn-glycerol lipid as active ingredients for a topical microbicide formulation targeting Chlamydia trachomatis.A central region in the minor capsid protein of papillomaviruses facilitates viral genome tethering and membrane penetration for mitotic nuclear entry.Identification of a dendrimeric heparan sulfate-binding peptide that inhibits infectivity of genital types of human papillomaviruses.Elucidating Molecular Interactions of Natural Inhibitors with HPV-16 E6 Oncoprotein through Docking Analysis Differential binding patterns to host cells associated with particles of several human alphapapillomavirus types.In vitro and in vivo evaluation of two carrageenan-based formulations to prevent HPV acquisition.Glycosaminoglycans and sialylated glycans sequentially facilitate Merkel cell polyomavirus infectious entry.Carrageenan as an adjuvant to enhance peptide-based vaccine potency Heterosexual anal sexuality and anal sex behaviors: a review.

P2860

Q21245129-B4D12BA0-5B8C-458D-8320-8C158CFEF497 Q21245131-F5DB811E-9F36-4EBF-A8C2-C0B73E524F92 Q21562543-9244C020-232C-48ED-9C79-289B76E0611E Q24616134-E4E179A7-3A61-441B-96EC-E62A534EA059 Q24630893-F9608E18-28DD-43F5-88C9-E808EDE52F45 Q26779076-0CB1A0D8-41FA-4F81-9431-F56DFAD4DECF Q26781302-B0259B4C-2F93-445B-A62D-72A8324EE375 Q26796360-7575FFB6-79F6-4327-810B-82EF7BC6AF77 Q26799484-BE8F2CD4-259A-4DC6-A56C-12CAB2AF566E Q26801497-5A577E0C-FEB9-4E66-8524-DA0A4794D21F Q26827796-5883CD45-8A92-47E7-B1B6-09F897A69B29 Q26861667-D901DE11-AEAC-41CD-A903-16AA567E0287 Q27012747-5143E7E3-F068-4F15-8991-33CBD68A63A2 Q27026900-75EDAE5C-A5CD-49F3-9C4D-792CC0786C0B Q27334384-19ADF526-7EA8-4E00-9E7A-43BD3E02780F Q27346336-51DD56D2-0502-4207-9251-4F8D902A4810 Q27666101-DF9FEA4A-7002-4F4C-983F-593717BE0710 Q28475787-58B1BE77-D247-40E0-8B96-B2A226EE0270 Q28534531-293CDD13-1442-4477-878A-7358D498ADBD Q28543716-A6D0BD53-F44A-4D08-AA42-E1608F09C0B4 Q28546239-65E8BB3B-7545-4E73-BE25-090BC43F4FF8 Q28547204-C40BE6E8-6390-473B-9D90-070F1F1FCCD2 Q28547982-87B3FAAC-FD33-48A1-9DFE-46C4D56A251E Q28744254-E72D7C29-951F-48E9-89CF-3FD17A0F7C76 Q30151464-D8B2CD9C-B36F-4D63-AF07-8E14082F78DC Q30278568-793045C5-C17B-4EC8-B05B-408C14313557 Q30369008-BE11EFDB-3A81-47B9-80C1-0648CC17757A Q30870696-CC87EB4B-5C8F-4AC4-B9D6-45E4CB39254E Q33464965-40F6E4F8-C7E4-4AA5-A256-4BF50CA08E4D Q33575647-4A7FBA7A-00AB-4558-AF3F-C948227EA8B4 Q33591582-2E376EE2-F35F-42DA-ABB2-D8A36218529F Q33613788-0E4ACEB5-0FDB-4DEF-8FA5-914A11BE4398 Q33626382-498F15B8-A6CA-4D09-B490-D6E8B5EFA2B6 Q33636333-1FC1A10C-EA51-4BAA-9836-DD59AC7981B7 Q33905693-D31C1B54-BD90-4AE3-8909-5AE5ADEF0B46 Q33923898-43D4509E-0967-445F-9C0E-07209218F553 Q33978803-8D0AA9CB-8281-427F-A9F6-1C978D43E7E4 Q33987448-30B7DB62-5180-423D-ACCB-3E608FC9C30F Q34012257-56678885-1788-4179-BE83-82B4D41B6890 Q34107809-8DAE404A-0486-403C-B68F-D3BE66DCC252

P2860

Carrageenan is a potent inhibitor of papillomavirus infection

http://www.wikidata.org/entity/Q21089628

description

2006 nî lūn-bûn

@nan

2006 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Carrageenan is a potent inhibitor of papillomavirus infection

@ast

Carrageenan is a potent inhibitor of papillomavirus infection

@en

Carrageenan is a potent inhibitor of papillomavirus infection

@en-gb

Carrageenan is a potent inhibitor of papillomavirus infection

@nl

type

label

Carrageenan is a potent inhibitor of papillomavirus infection

@ast

Carrageenan is a potent inhibitor of papillomavirus infection

@en

Carrageenan is a potent inhibitor of papillomavirus infection

@en-gb

Carrageenan is a potent inhibitor of papillomavirus infection

@nl

altLabel

Carrageenan Is a Potent Inhibitor of Papillomavirus Infection

@en

prefLabel

Carrageenan is a potent inhibitor of papillomavirus infection

@ast

Carrageenan is a potent inhibitor of papillomavirus infection

@en

Carrageenan is a potent inhibitor of papillomavirus infection

@en-gb

Carrageenan is a potent inhibitor of papillomavirus infection

@nl

P1433

Q21089628-4E423557-1985-4DB2-9FEE-B691E2857B40

P1476

Q21089628-F191C12B-300D-4581-A826-5C5445F10795

P2093

Q21089628-293F6C2A-FF41-4079-B942-5478A30A8780

Q21089628-4CEA4CA7-8B88-4EC8-9C09-CCF321A6C043

Q21089628-8A6D6376-BD8A-47C9-B860-A77BD16FBCC9

Q21089628-CBE5C318-3D67-41C1-98B5-0E2AADFC4274

Q21089628-F5205664-5CE0-463D-BE1A-5D63F4EE0401

P2860

Q21089628-058E324E-589D-42F3-8363-5B803E5C9C0D

Q21089628-08BB5294-6D5F-4AD3-9027-5400D1B4E4AA

Q21089628-0A4247DC-7423-46E2-95E3-A6F6424BB81C

Q21089628-0F9CB6E3-0F1A-4F79-BC32-803BDBD06D78

Q21089628-1215DAC4-8914-42B5-A561-60FA53B438BB

Q21089628-1493365C-72A2-4623-AA73-5A33F98398AB

Q21089628-1F00DC8C-D135-48B1-A180-B072F703DA81

Q21089628-1F6E49C1-5EEE-452A-B311-45CAD6EDF445

Q21089628-27221F5C-6191-45A0-99D2-3F1D8D2A3197

Q21089628-298B2C27-44ED-4EC8-869F-190715DC666D

P304

Q21089628-7CDF6238-5961-4295-B004-A9FA126587BD

P31

Q21089628-DB748D1C-0749-4EDF-931C-B1B666A1049D

P3181

Q21089628-CBC317A4-C438-4C86-AA03-D1FA0B48CB63

P356

Q21089628-832C8751-E294-4DC0-8C60-4C546A1F4EAE

P407

Q21089628-FAB909DD-F37A-4F9F-9382-B4A8465C43E4

P433

Q21089628-9CBA2CC6-1AC1-4D29-A8AC-048BF1AF28A5

P478

Q21089628-FFE1EBAB-76F6-4CEE-BB33-183539546197

P50

Q21089628-1C37F916-7A08-4570-A95B-80FCDDAA7CEB

P577

Q21089628-A7FAF63C-4B0E-4891-A184-C014E3C8A210

P5875

Q21089628-D723ACC4-B315-45D0-86EC-09032EA5CA38

P698

Q21089628-F4381AE5-D30C-4BF1-9AA3-1E6721FC02B1

P921

Q21089628-19DE409C-5921-45E8-8150-AAC93F74F4C4

P932

Q21089628-6ECDA9BF-9B03-4A81-86F3-2E67EC58EF2A

P3181

P356

JOURNAL.PPAT.0020069

P1433

P1476

Carrageenan is a potent inhibitor of papillomavirus infection

@en

P2093

Cynthia D Thompson

http://www.w3.org/2001/XMLSchema#string

Douglas R Lowy

http://www.w3.org/2001/XMLSchema#string

Jeffrey N Roberts

http://www.w3.org/2001/XMLSchema#string

John T Schiller

http://www.w3.org/2001/XMLSchema#string

Martin Müller

http://www.w3.org/2001/XMLSchema#string

P2860

Human papillomavirus infection requires cell surface heparan sulfate.

Review of harmful gastrointestinal effects of carrageenan in animal experiments.

The papillomavirus life cycle

Animal cell mutants defective in glycosaminoglycan biosynthesis

Inhibitory effect of tachyplesin I on the proliferation of human immunodeficiency virus in vitro

Polysaccharides as antiviral agents: antiviral activity of carrageenan

A broad-spectrum microbicide with virucidal activity against sexually transmitted viruses

Classification of papillomaviruses

Order out of chaos: assembly of ligand binding sites in heparan sulfate

The spermicide nonoxynol-9 does not inactivate papillomavirus.

P304

e69

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

596102

http://www.w3.org/2001/XMLSchema#string

P356

10.1371/JOURNAL.PPAT.0020069

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P50

Christopher B. Buck

P577

2006-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6946875

http://www.w3.org/2001/XMLSchema#string

P698

16839203

http://www.w3.org/2001/XMLSchema#string

P921

P932

1500806

http://www.w3.org/2001/XMLSchema#string